{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:56:09Z","timestamp":1791262569605,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T00:00:00Z","timestamp":1399420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s10549-014-2972-0","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T09:26:31Z","timestamp":1399368391000},"page":"775-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan"],"prefix":"10.1007","volume":"145","author":[{"given":"Muhammad U.","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"issue":"5581","key":"2972_CR1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","volume":"297","author":"NG Howlett","year":"2002","unstructured":"Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D\u2019Andrea AD (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297(5581):606\u2013609","journal-title":"Science"},{"issue":"2","key":"2972_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39(2):159\u2013161","journal-title":"Nat Genet"},{"issue":"9","key":"2972_CR3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ng1624","volume":"37","author":"O Levran","year":"2005","unstructured":"Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, Ott J, Petrini J, Schindler D, Hanenberg H, Auerbach AD (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37(9):931\u2013933","journal-title":"Nat Genet"},{"issue":"5","key":"2972_CR4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","volume":"42","author":"F Vaz","year":"2010","unstructured":"Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42(5):406\u2013409","journal-title":"Nat Genet"},{"issue":"5","key":"2972_CR5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410\u2013414","journal-title":"Nat Genet"},{"issue":"4","key":"2972_CR6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/bcr2619","volume":"12","author":"MR Akbari","year":"2010","unstructured":"Akbari MR, Tonin P, Foulkes WD, Ghadirian P, Tischkowitz M, Narod SA (2010) RAD51C germline mutations in breast and ovarian cancer patients. Breast Cancer Res 12(4):404\u2013405","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2972_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-012-1998-4","volume":"133","author":"K Leeneer De","year":"2012","unstructured":"De Leeneer K, Van BM, De BS, Swietek N, Schietecatte P, Sabbaghian N, Van den EJ, Willocx S, Storm K, Blaumeiser B, van Asperen CJ, Wijnen JT, Leunen K, Legius E, Michils G, Matthijs G, Blok MJ, Gomez-Garcia E, De PA, Tischkowitz M, Poppe B, Claes K (2012) Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing. Breast Cancer Res Treat 133(1):393\u2013398","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2972_CR8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10689-012-9523-9","volume":"11","author":"W Lu","year":"2012","unstructured":"Lu W, Wang X, Lin H, Lindor NM, Couch FJ (2012) Mutation screening of RAD51C in high-risk breast and ovarian cancer families. Fam Cancer 11(3):381\u2013385","journal-title":"Fam Cancer"},{"issue":"3","key":"2972_CR9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10549-010-1095-5","volume":"124","author":"Y Zheng","year":"2010","unstructured":"Zheng Y, Zhang J, Hope K, Niu Q, Huo D, Olopade OI (2010) Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Res Treat 124(3):857\u2013861","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2972_CR10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-011-1443-0","volume":"127","author":"MW Wong","year":"2011","unstructured":"Wong MW, Nordfors C, Mossman D, Pecenpetelovska G, Very-Kiejda KA, Talseth-Palmer B, Bowden NA, Scott RJ (2011) BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat 127(3):853\u2013859","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2972_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10549-012-2317-9","volume":"136","author":"A Kushnir","year":"2012","unstructured":"Kushnir A, Laitman Y, Shimon SP, Berger R, Friedman E (2012) Germline mutations in RAD51C in Jewish high cancer risk families. Breast Cancer Res Treat 136(3):869\u2013874","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"2972_CR12","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1093\/hmg\/dds115","volume":"21","author":"A Osorio","year":"2012","unstructured":"Osorio A, Endt D, Fernandez F, Eirich K, de la Hoya M, Schmutzler R, Caldes T, Meindl A, Schindler D, Benitez J (2012) Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. Hum Mol Genet 21(13):2889\u20132898","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2972_CR13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10549-011-1543-x","volume":"129","author":"A Romero","year":"2011","unstructured":"Romero A, Perez-Segura P, Tosar A, Garcia-Saenz JA, Az-Rubio E, Caldes T, de la Hoya M (2011) A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families. Breast Cancer Res Treat 129(3):939\u2013946","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2972_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2224","volume":"44","author":"C Loveday","year":"2012","unstructured":"Loveday C, Turnbull C, Ruark E, Xicola RM, Ramsay E, Hughes D, Warren-Perry M, Snape K, Eccles D, Evans DG, Gore M, Renwick A, Seal S, Antoniou AC, Rahman N (2012) Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat Genet 44(5):475\u2013476","journal-title":"Nat Genet"},{"issue":"1","key":"2972_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/humu.21625","volume":"33","author":"ER Thompson","year":"2012","unstructured":"Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DYH, kConFab, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG (2012) Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat 33(1):95\u201399","journal-title":"Hum Mutat"},{"issue":"4","key":"2972_CR16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1399-0004.2012.01917.x","volume":"83","author":"F Coulet","year":"2013","unstructured":"Coulet F, Fajac A, Colas C, Eyries M, Dion-Miniere A, Rouzier R, Uzan S, Lefranc JP, Carbonnel M, Cornelis F, Cortez A, Soubrier F (2013) Germline RAD51C mutations in ovarian cancer susceptibility. Clin Genet 83(4):332\u2013336","journal-title":"Clin Genet"},{"issue":"3","key":"2972_CR17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10549-011-1677-x","volume":"130","author":"M Vuorela","year":"2011","unstructured":"Vuorela M, Pylkas K, Hartikainen JM, Sundfeldt K, Lindblom A, von Wachenfeldt WA, Haanpaa M, Puistola U, Rosengren A, Anttila M, Kosma VM, Mannermaa A, Winqvist R (2011) Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast Cancer Res Treat 130(3):1003\u20131010","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"2972_CR18","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1093\/hmg\/ddr229","volume":"20","author":"LM Pelttari","year":"2011","unstructured":"Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittomaki K, Butzow R, Nevanlinna H (2011) RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet 20(16):3278\u20133288","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2972_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10549-011-1574-3","volume":"129","author":"Z Pang","year":"2011","unstructured":"Pang Z, Yao L, Zhang J, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y (2011) RAD51C germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat 129(3):1019\u20131020","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2972_CR20","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/ijc.22269","volume":"119","author":"MU Rashid","year":"2006","unstructured":"Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119(12):2832\u20132839","journal-title":"Int J Cancer"},{"issue":"2","key":"2972_CR21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10689-012-9509-7","volume":"11","author":"MU Rashid","year":"2012","unstructured":"Rashid MU, Gull S, Asghar K, Muhammad N, Amin A, Hamann U (2012) Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients. Fam Cancer 11(2):307\u2013311","journal-title":"Fam Cancer"},{"issue":"6","key":"2972_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-13-312","volume":"13","author":"MU Rashid","year":"2013","unstructured":"Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U (2013) Constitutional CHEK2 mutations are infrequent in early-onset and familial breast\/ovarian cancer patients from Pakistan. BMC Cancer 13(6):312\u2013318","journal-title":"BMC Cancer"},{"issue":"1","key":"2972_CR23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/bcr2823","volume":"13","author":"V Silvestri","year":"2011","unstructured":"Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Palli D, Ottini L (2011) Mutation screening of RAD51C in male breast cancer patients. Breast Cancer Res 13(1):404\u2013405","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2972_CR24","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/bcr3589","volume":"15","author":"G Schnurbein","year":"2013","unstructured":"Schnurbein G, Hauke J, Wappenschmidt B, Weber-Lassalle N, Engert S, Hellebrand H, Garbes L, Becker A, Neidhardt G, Rhiem K, Meindl A, Schmutzler RK, Hahnen E (2013) RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families. Breast Cancer Res 15(6):R120","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2972_CR25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28(6):622\u2013629","journal-title":"Hum Mutat"},{"issue":"7","key":"2972_CR26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/humu.20492","volume":"28","author":"PA Chan","year":"2007","unstructured":"Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, Raevaara T, Ollila S, Nystrom M, Grimm AJ, Christodoulou J, Oetting WS, Greenblatt MS (2007) Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 28(7):683\u2013693","journal-title":"Hum Mutat"},{"issue":"2\u20134","key":"2972_CR27","first-page":"251","volume":"15","author":"K Usmani","year":"1996","unstructured":"Usmani K, Khanum A, Afzal H, Ahmad N (1996) Breast carcinoma in Pakistani women. J Environ Pathol Toxicol Oncol 15(2\u20134):251\u2013253","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"2","key":"2972_CR28","first-page":"215","volume":"8","author":"Y Bhurgri","year":"2007","unstructured":"Bhurgri Y, Kayani N, Faridi N, Pervez S, Usman A, Bhurgri H, Malik J, Bashir I, Bhurgri A, Hasan SH, Zaidi SH (2007) Patho-epidemiology of breast cancer in Karachi \u20181995\u20131997\u2019. Asian Pac J Cancer Prev 8(2):215\u2013220","journal-title":"Asian Pac J Cancer Prev"},{"key":"2972_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2407-10-191","volume":"10","author":"M Kakarala","year":"2010","unstructured":"Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE (2010) Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S\u2014a SEER analysis. BMC Cancer 10:191","journal-title":"BMC Cancer"},{"issue":"2","key":"2972_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10549-011-1362-0","volume":"128","author":"MS Moran","year":"2011","unstructured":"Moran MS, Gonsalves L, Goss DM, Ma S (2011) Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival. Breast Cancer Res Treat 128(2):543\u2013551","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2972_CR31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.oraloncology.2013.11.007","volume":"50","author":"K Scheckenbach","year":"2014","unstructured":"Scheckenbach K, Baldus SE, Balz V, Freund M, Pakropa P, Sproll C, Schafer KL, Wagenmann M, Schipper J, Hanenberg H (2014) RAD51C\u2014a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral Oncol 50(3):196\u2013199","journal-title":"Oral Oncol"},{"issue":"9","key":"2972_CR32","doi-asserted-by":"crossref","first-page":"e25632","DOI":"10.1371\/journal.pone.0025632","volume":"6","author":"J Clague","year":"2011","unstructured":"Clague J, Wilhoite G, Adamson A, Bailis A, Weitzel JN, Neuhausen SL (2011) RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. PLoS ONE 6(9):e25632","journal-title":"PLoS ONE"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-2972-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2972-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:47:31Z","timestamp":1559234851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-2972-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2972"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-2972-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]}}}